Identification of amino acids in highly pathogenic avian influenza H5N1 virus hemagglutinin that determine avian influenza species specificity

Archives of Virology

Volumn 156, Issue 10, 2011, Pages 1803-1812

  Li, Zheng ^a   Liu, Zhonghua ^b   Ma, Chi ^a   Zhang, Linqi ^b   Su, Yuelong ^c   Gao, George F ^d   Li, Zi ^c   Cui, Lianxian ^a   He, Wei ^a  

^a INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

^b INSTITUTE OF PATHOGEN BIOLOGY   (China)

^c CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^d INSTITUTE OF MICROBIOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

H1N1 VIRUS HEMAGGLUTININ; INFLUENZA VIRUS HEMAGGLUTININ; VIRUS ANTIBODY;

AMINO ACID SEQUENCE; ANIMAL; ARTICLE; AVIAN INFLUENZA; BIRD; CELL LINE; CHEMISTRY; GENETICS; HOST RANGE; HUMAN; IMMUNOLOGY; INFLUENZA; INFLUENZA VIRUS A H5N1; MOLECULAR GENETICS; MUTATION; PATHOGENICITY; PHYSIOLOGY; PROTEIN MOTIF; PROTEIN TERTIARY STRUCTURE; VIROLOGY;

AMINO ACID MOTIFS; AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, VIRAL; BIRDS; CELL LINE; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HOST SPECIFICITY; HUMANS; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA IN BIRDS; INFLUENZA, HUMAN; MOLECULAR SEQUENCE DATA; MUTATION; PROTEIN STRUCTURE, TERTIARY;

AVES; ORTHOMYXOVIRIDAE;

EID: 80053196836     PISSN: 03048608     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00705-011-1056-2     Document Type: Article

References (31)

1. Burton DR (2002) Antibodies, viruses and vaccines. Nature 2: 706-713.
2. Chandrasekaran A, Srinivasan A, Raman R, Viswanathan K, Raguram S, Tumpey TM, Sasisekharan V, Sasisekharan R (2008) Glycan topology determines human adaptation of avian H5N1 virus hemagglutinin. Nat Biotechnol 26: 107-113.
3. Gao Y, Zhang Y, Shinya K, Deng G, Jiang Y, Li Z, Guan Y, Tian G, Li Y, Shi J, Liu L, Zeng X, Bu Z, Xia X, Kawaoka Y, Chen H (2009) Identification of amino acids in HA and PB2 critical for the transmission of H5N1 avian influenza viruses in a mammalian host. PLoS Pathog 5: e1000709.
4. Guo CT, Takahashi N, Yagi H, Kato K, Takahashi T, Yi SQ, Chen Y, Ito T, Otsuki K, Kida H, Kawaoka Y, Hidari KI, Miyamoto D, Suzuki T, Suzuki Y (2007) The quail and chicken intestine have sialyl-galactose sugar chains responsible for the binding of influenza A viruses to human type receptors. Glycobiology 17: 713-724.
5. Hangartner L, Zinkernagel RM, Hengartner H (2006) Antiviral antibody responses: the two extremes of a wild spectrum. Nat Rev Immunol 6: 231-241.
6. Hensley SE, Das SR, Bailey AL, Schmidt LM, Hickman HD, Jayaraman A, Viswanathan K, Raman R, Sasisekharan R, Bennink JR, Yewdell JW (2009) Hemagglutinin receptor binding avidity drives influenza A virus antigenic drift. Science 326: 734-736.
7. He Y, Li J, Jiang S (2006) A single amino acid substitution (R441A) in the receptor-binding domain of SARS coronavirus spike protein disrupts the antigenic structure and binding activity. Biochem Biophys Res Commun 344: 106-113.
8. Karlsson Hedestam GB, Fouchier RA, Phogat S, Burton DR, Sodroski J, Wyatt RT (2008) The challenges of eliciting neutralizing antibodies to HIV-1 and to influenza virus. Nat Rev Microbiol 6: 143-155.
9. Khurana S, Suguitan AL Jr, Rivera Y, Simmons CP, Lanzavecchia A, Sallusto F, Manischewitz J, King LR, Subbarao K, Golding H (2009) Antigenic fingerprinting of H5N1 avian influenza using convalescent sera and monoclonal antibodies reveals potential vaccine and diagnostic targets. PLoS Med 6: e100049.
10. Kuiken T, Holmes EC, McCauley J, Rimmelzwaan GF, Williams CS, Grenfell BT (2006) Host species barriers to influenza virus infections. Science 21: 394-397.
11. Liu J, Xiao H, Lei F, Zhu Q, Qin K, Zhang XW, Zhang XL, Zhao D, Wang G, Feng Y, Ma J, Liu W, Wang J, Gao GF (2005) Highly pathogenic H5N1 influenza virus infection in migratory birds. Science 309: 1206.
12. Li Z, Ma C, Liu Z, He W (2011) Serologic cross-reactivity among humans and birds infected with highly pathogenic avian influenza A subtype H5N1 viruses in China. Immunol Lett 135: 59-63.
13. Luo W, Chen Y, Wang M, Chen Y, Zheng Z, Song H, Chen H, Guan Y, Ng MH, Zhang J, Xia N (2009) Peptide mimics of a conserved H5N1 avian influenza virus neutralization site. Biochem J 419: 133-139.
14. Marasco WA, Sui J (2007) The growth and potential of human antiviral monoclonal antibody therapeutics. Nature Biotechnol 25: 1421-1434.
15. Martinez O, Tsibane T, Basler CF (2009) Neutralizing anti-influenza virus monoclonal antibodies: therapeutics and tool for discovery. Int Rev Immunol 28: 69-92.
16. Nakajima S, Nakajima K, Nobusawa E, Zhao J, Tanaka S, Fukuzawa K (2007) Comparison of epitope structures of H3HAs through protein modeling of influenza A virus hemagglutinin: mechanism for selection of antigenic variants in the presence of a monoclonal antibody. Microbiol Immunol 51: 1179-1187.
17. Ndifon W, Wingreen NS, Levin SA (2009) Differential neutralization efficiency of hemagglutinin epitopes, antibody interference, and the design of influenza vaccines. PNAS 106: 8701-8706.
18. Nelson MI, Holmes EC (2007) The evolution of epidemic influenza. Nature 8: 196-205.
19. Nicholls JM, Chan MC, Chan WY, Wong HK, Cheung CY, Kwong DL, Wong MP, Chui WH, Poon LL, Tsao SW, Guan Y, Peiris JS (2007) Tropism of avian influenza A (H5N1) in the upper and lower respiratory tract. Nat Med 13: 147-149.
20. Pinschewer DD, Perez M, Jeetendra E, Bächi T, Horvath E, Hengartner H, Whitt MA, de la Torre JC, Zinkernagel RM (2004) Kinetics of protective antibodies are determined by the viral surface antigen. J Clin Invest 114: 988-993.
21. Shih AC, Hsiao TC, Ho MS, Li WH (2007) Simultaneous amino acid substitutions at antigenic sites drive influenza A hemagglutinin evolution. PNAS 104: 6283-6288.
22. Shinya K, Ebina M, Yamada S, Ono M, Kasai N, Kawaoka Y (2006) Avian flu: influenza virus receptors in the human airway. Nature 440: 435-436.
23. Skehel JJ, Wiley DC (2000) Receptor binding and membrane fusion in virus entry: the Influenza hemagglutinin. Annu Rev Biochem 69: 531-569.
24. Stevens J, Blixt O, Tumpey TM, Taubenberger JK, Paulson JC, Wilson IA (2006) Structure and receptor specificity of the hemagglutinin from an H5N1 influenza virus. Science 312: 404-410.
25. Sui J, Aird DR, Tamin A, Murakami A, Yan M, Yammanuru A, Jing H, Kan B, Liu X, Zhu Q, Yuan QA, Adams GP, Bellini WJ, Xu J, Anderson LJ, Marasco WA (2008) Broadening of neutralization activity to directly block a dominant antibody-driven SARS-coronavirus evolution pathway. PLoS Pathog 4: e1000197.
26. Sui J, Hwang WC, Perez S, Wei G, Aird D, Chen LM, Santelli E, Stec B, Cadwell G, Ali M, Wan H, Murakami A, Yammanuru A, Han T, Cox NJ, Bankston LA, Donis RO, Liddington RC, Marasco WA (2009) Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses. Nat Struct Mol Biol 16: 265-273.
27. Suzuki Y (2006) Natural selection on the influenza virus genome. Mol Biol Evol 23: 1902-1911.
28. Takematsu K, Fukuzawa K, Omagari K, Nakajima S, Nakajima K, Mochizuki Y, Nakano T, Watanabe H, Tanaka S (2009) Possibility of mutation prediction of influenza hemagglutinin by combination of hemadsorption experiment and quantum chemical calculation for antibody binding. J Phys Chem B 113: 4991-4994.
29. Totani K, Kubota T, Kuroda T, Murata T, Hidari KI, Suzuki T, Suzuki Y, Kobayashi K, Ashida H, Yamamoto K, Usui T (2003) Chemoenzymatic synthesis and application of glycopolymers containing multivalent sialyloligosaccharides with a poly (L-glutamic acid) backbone for inhibition of infection by influenza viruses. Glycobiology 13: 315-326.
30. Yang ZY, Wei CJ, Kong WP, Wu L, Xu L, Smith DF, Nabel GJ (2007) Immunization by avian H5 influenza hemagglutinin mutants with altered receptor binding specificity. Science 317: 825-828.
31. Yamada S, Suzuki Y, Suzuki T, Le MQ, Nidom CA, Sakai-Tagawa Y, Muramoto Y, Ito M, Kiso M, Horimoto T, Shinya K, Sawada T, Kiso M, Usui T, Murata T, Lin Y, Hay A, Haire LF, Stevens DJ, Russell RJ, Gamblin SJ, Skehel JJ, Kawaoka Y (2006) Haemagglutinin mutations responsible for the binding of H5N1 influenza A viruses to human-type receptors. Nature 444: 378-382.